STAT+: Roche inks drug discovery deal with Chinese biotech, focused on molecular glue medicines

🌐 STAT News Health (United States) —
STAT+: Roche inks drug discovery deal with Chinese biotech, focused on molecular glue medicines

AI Summary

Roche has signed a drug-discovery agreement with Chinese biotech company Defand Therapeutics focused on molecular glue medicines. The announcement concerns a pharmaceutical research collaboration.

Roche has inked a drug discovery deal with Chinese biotech Defand Therapeutics, focused on molecular glue medicines.

Deals Health Roche Defand Therapeutics drug discovery biotechnology molecular glue pharmaceutical partnership

Read original source →